In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device/Diagnostics Quarterly Dealmaking Statistics, Q2 2018

A look at the financing, M&A and alliance activity in April-June 2018

Executive Summary

Second quarter device financing totaled $3.4 billion, less than half of the Q1 aggregate. Conversely, the $10.6 billion in device M&As was a 58% upsurge over the previous quarter. Like the device trends, total Q2 diagnostics financings (at $959 million) showed a 36% decline from Q1, while the $4.8 billion in M&A volume exhibited a significant increase over the previous quarter.

 

Advertisement

Related Content

FDA's Speedy Apple Watch De Novos Raise Questions For Industry
The Medtech Conference: Industry Is Falling Short In Digital Investments
Bringing The Clinician's Rationale Into The Heart Of Strategic Decision-Making At Boston Scientific
CMR Surgical Launches Robotic System To Rival Intuitive’s Da Vinci
Novartis Sees The Light And Plumps For Alcon Spin-Off
GE Spins Off Healthcare As Part Of Major Reorganization
Roche Pushes Personalization With $2.4bn Foundation Buy-Out
CMR Surgical's Versius Close To Launch With $100m Round
Myriad Genetics Grows Women's Health Biz With Counsyl Acquisition
Bono-Backed Investment Fund Props Reflexion Medical In Final Funding Round

Topics

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV123567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel